NeuroOne Medical Technologies Corporation — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+32.1% +$2M
$9M
Current Assets↑+41.2% +$2M
$8M
Cash & Equivalents↑+214.0% +$2M
$4M
ST Investments
—
Receivables↑+12.4% +$293K
$3M
Inventory↓-13.7% -$265K
$2M
Net PPE↓-35.8% -$137K
$245K
Intangibles↓-36.2% -$22K
$39K
Total Liabilities↓-38.9% -$1M
$2M
Current Liabilities↓-19.9% -$312K
$1M
Account Payables↓-25.8% -$192K
$552K
Short-Term Debt
$122K
Stockholders Equity↑+118.1% +$3M
$6M
Retained Earnings↓-9.3% -$7M
$-80M
Operating Lease ROU Asset↓-33.3% -$113K
$226K
Operating Lease Liability↓-30.5% -$104K
$237K
Gross PP&E↑+10.3% +$103K
$1M
Accumulated Depreciation↑+38.7% +$240K
$859K
Inventory Raw Materials
—
Inventory WIP
$10K
Inventory Finished Goods↓-41.1% -$362K
$518K
Total Debt Carrying Amount
—
Contract Liability
—